Revisit the key moments of ATS 2025. Access all the inspiring presentations, valuable clinical insights, and presentations from pulmonary, critical care, and sleep sessions with our ATS Conference Highlight packages. Check out the package options below and pick the one that's right for you.
Learn at your own pace, whenever and wherever you are.
Add-On to In-Person Conference Registration
$50 member $75 non-member
Access equivalent to the All Access Pass package
CME is not available for on demand sessions.
Abstracts Package
$439 member $549 non-member
On Demand access to 30+ Abstract Sessions (Mini Symposia, RAPiD Poster Discussion Sessions)
Access to ePosters
On Demand access to Keynote Series
Access to livestreaming
Bookmark sessions and browse abstracts
Network (Send connection requests, follow, and explore our extensive network of attendees)
Browse Exhibitors
On Demand access to Industry Programming
Post Conference Webinars
Accessible until March 2026
CME is not available for on demand sessions.
×
Livestream
G1 Opening Ceremony
CC1 ADULT CRITICAL CARE CORE CURRICULUM
CC2 ADULT PULMONARY CLINICAL CORE CURRICULUM
K1 PROVIDING HEALTH CARE FOR UNHOUSED INDIVIDUALS
A1 CLINICAL YEAR IN REVIEW
CC3 ADULT CRITICAL CARE CORE CURRICULUM
CC4 ADULT PULMONARY CLINICAL CORE CURRICULUM
K2 THE DEVELOPMENT OF GENETIC THERAPIES FOR PEOPLE WITH RESPIRATORY DISEASE
B1 CLINICAL YEAR IN REVIEW
K3 NASA’S ENVIRONMENTAL DATA ON POLLUTION, CLEAN AIR, AND ENVIRONMENTAL IMPACT
G6 Plenary Session
CC5 ADULT SLEEP CLINICAL CORE CURRICULUM
C1 CLINICAL YEAR IN REVIEW
CC6 ADULT SLEEP CLINICAL CORE CURRICULUM
D1 CLINICAL YEAR IN REVIEW
On Demand
K1 PROVIDING HEALTH CARE FOR UNHOUSED INDIVIDUALS
A3 FELLOWS CASE CONFERENCE
A14 ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF ILD
A15 PRIMARY AND SECONDARY RESULTS FROM CLINICAL TRIALS: COPD AND PLEURAL DISEASE
A17 TUBERCULOSIS: STILL KICKING, STILL HIDING - SCIENCE, SPREAD, AND WHAT WE’RE DOING ABOUT IT
A18 BEST TRIALS IN PULMONARY REHABILITATION
A28 DEEPER DIVES, GREATER IMPACT: LEVERAGING SECONDARY ANALYSES IN CRITICAL CARE TRIALS
A31 THE EVOLVING LANDSCAPE OF BRONCHOPULMONARY DYSPLASIA: MAKING STRIDES
A83 GREAT CASES: CLINICAL, RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER CLINICIANS
A82 BREAKING NEWS: 2025 CLINICAL TRIAL RESULTS IN PULMONARY MEDICINE
A95 NEW AND EXCITING BIOMARKERS IN ILD
A96 ADVANCES IN COPD
A97 FROM SURVIVING TO THRIVING: UNDERSTANDING AND IMPROVING LONG TERM OUTCOMES AFTER CRITICAL ILLNESS
A100 REIMAGINING RELIEF: ADVANCES IN PHARMACOTHERAPY AND NERVE STIMULATION FOR SLEEP APNEA TREATMENT
A109 SMOKE, SNOOZE, AND ICU BLUES: THE INFLUENCE OF ENVIRONMENTAL EXPOSURES AND CRITICAL CARE CONDITIONS ON SLEEP
A110 MECHANISMS OF LUNG TUMORIGENESIS, TRANSITION AND TARGETED THERAPEUTICS
B16 SUBPHENOTYPING ARDS: FROM THE WHOLE PERSON DOWN TO THE CELL
B17 THE POWER OF TEAM SCIENCE: INTERDISCIPLINARY APPROACHES TO PULMONARY AND CRITICAL CARE
B18 BEST IN PEDIATRICS
B19 ON LOMBARD STREET: CELLULAR PATHOPHYSIOLOGY OF PULMONARY VASCULAR DISEASE: FROM EPIGENETIC AND MOLECULAR DRIVERS TO TREATMENT TARGETS
B20 NTM, BRONCHIECTASIS, AND THE QUEST TO UNDERSTAND: A STORY OF LUNGS AND LOVE
B26 ORACLE PARK: VASCULAR ABNORMALITIES, RISK STRATIFICATION, AND CLINICAL MANAGEMENT OF PULMONARY HYPERTENSION
B14 FROM INFLAMMATION TO INFECTION: EXPLORING BREAKTHROUGHS IN AIRWAYS DISEASE
B93 COPD EPIDEMIOLOGY AND MANAGEMENT
B94 UNRAVELING THE CODE OF ENVIRONMENTAL EXPOSURE: RESPONSE WITH EPIGENETICS AND OMICS
B96 CROSSING THE GOLDEN GATE BRIDGE: CLINICAL TRIALS, TARGETED THERAPIES AND NOVEL APPROACHES IN PULMONARY ARTERIAL HYPERTENSION
B97 IT'S A VIRUS PARTY! FLU, PARAINFLUENZA, RSV, COVID, AND A LITTLE HIV
B98 CELLULAR INTERACTIONS AND SIGNALING NETWORKS IN PULMONARY FIBROSIS
B100 REVOLUTIONIZING NODULE MANAGEMENT AND LUNG CANCER DIAGNOSIS: FROM PREDICTIVE MODELS TO ADVANCED INTERVENTIONS
B102 MEDICAL EDUCATION IN PULMONARY AND CRITICAL CARE MEDICINE
B107 WHAT'S NEW IN PULMONARY REHABILITATION ASSESSMENT STRATEGIES?
C3 PEDIATRIC CLINICAL CHEST ROUNDS
C14 STRENGTHENING YOUR "-ABS": CLINICAL THERAPEUTICS FOR INFLAMMATORY LUNG DISEASE
C15 OMICS ODYSSEY ACROSS LUNG DISEASES
C17 DELIRIUM, DISPARITIES, AND DISABILITY: ADVANCING EQUITY IN CRITICAL ILLNESS OUTCOMES
C19 UNCOVERING DEEP ROOTS: NEW MECHANISMS IN AIRWAY DISEASE
C20 CROSSING THE GOLDEN GATE: INNOVATIVE OSA TREATMENT TRIALS AND CARDIOVASCULAR OUTCOMES
C26 SMOKE, HEAT, AND HEALTH: LUNG DISEASE IN THE AGE OF CLIMATE CHANGE AND WILDFIRES
C28 TB, NTM, AND PNEUMONIA: THE RESPIRATORY TRIO YOU DIDN’T INVITE TO THE PARTY
C94 BREATHING EASY: UNRAVELING THE MYSTERIES OF ASTHMA THROUGH TRANSLATIONAL STUDIES
C96 SEPSIS SCIENCE: OPTIMIZING PERSONALIZATION AND PROCESS
C97 CUTTING-EDGE ADVANCES IN PEDIATRIC LUNG DISEASES: FROM PREDICTION TO MANAGEMENT
C98 PALACE OF FINE ARTS: INNOVATIVE THERAPEUTIC APPROACHES AND SURVIVAL PREDICTION IN PULMONARY HYPERTENSION
C100 MORNING SHOWS THE DAY: PERINATAL DETERMINANTS OF AIRWAY STRUCTURE AND FUNCTION
C105 UPDATES ON MONITORING AND TREATMENT OF PEDIATRIC LUNG DISEASES ACROSS THE GLOBE
D13 CURRENT RESEARCH IN CRITICAL AND ACUTE CARE
D14 LESSONS FROM CLINICAL STUDIES IN COPD
D16 INDOOR/OUTDOOR AIR POLLUTION: UNCOVERING DISPARITIES AND ADVANCING LUNG HEALTH
D91 IMAGING-BASED ADVANCES IN FIBROTIC ILD
D92 BIOMARKERS AND PREDICTIVE TOOLS IN COPD
D93 SUPPORTING LIFE AROUND THE GLOBE: OXYGEN, VENTILATION, AND CARDIAC ARREST SCIENCE
D94 INROADS INTO NOVEL THERAPEUTICS AND DELIVERY APPROACHES FOR PEDIATRIC LUNG DISEASES
D98 TRACING THE SCAR IN INTERSTITIAL LUNG DISEASES
Symposia Package
$439 member $549 non-member
On Demand access to scientific symposia including but not limited to: Clinical Year in Review, Pediatric Year in Review, Keynote Series, Adult Clinical Core Curriculum, Pediatric Clinical Core Curriculum, Great Cases: Clinical, Radiologic, and Pathologic Correlations by Master Clinicians, Fellows Case Conference, Pediatric Clinical Chest Round, Late Breaking Clinical Trial Symposium, AJRCCM, JAMA, NEJM Discussions on the Edge: Critical Care and Pulmonary Research Journal Sessions.
Access to livestreaming
Bookmark sessions and access to ePosters
Network (Send connection requests, follow, and explore our extensive network of attendees)
Browse Exhibitors
On Demand access to Industry Programming
Post Conference Webinars
Accessible until March 2026
CME is not available for on demand sessions.
×
Livestream
G1 Opening Ceremony
CC1 ADULT CRITICAL CARE CORE CURRICULUM
CC2 ADULT PULMONARY CLINICAL CORE CURRICULUM
K1 PROVIDING HEALTH CARE FOR UNHOUSED INDIVIDUALS
A1 CLINICAL YEAR IN REVIEW
CC3 ADULT CRITICAL CARE CORE CURRICULUM
CC4 ADULT PULMONARY CLINICAL CORE CURRICULUM
K2 THE DEVELOPMENT OF GENETIC THERAPIES FOR PEOPLE WITH RESPIRATORY DISEASE
B1 CLINICAL YEAR IN REVIEW
K3 NASA’S ENVIRONMENTAL DATA ON POLLUTION, CLEAN AIR, AND ENVIRONMENTAL IMPACT
G6 Plenary Session
CC5 ADULT SLEEP CLINICAL CORE CURRICULUM
C1 CLINICAL YEAR IN REVIEW
CC6 ADULT SLEEP CLINICAL CORE CURRICULUM
D1 CLINICAL YEAR IN REVIEW
On Demand
G1 OPENING CEREMONY
K1 PROVIDING HEALTH CARE FOR UNHOUSED INDIVIDUALS
A10 TRUE GRIT: TALES OF IMPACTFUL SCIENCE IN DRUG DEVELOPMENT, CLINICAL TRIALS, GLOBAL REGISTRIES AND BIOBANKS FOR PULMONARY ARTERIAL HYPERTENSION
A11 CENTENNIAL CELEBRATION OF VA'S RESEARCH AND DEVELOPMENT PROGRAM
A1 CLINICAL YEAR IN REVIEW
A3 FELLOWS CASE CONFERENCE
PCC1 PEDIATRIC CLINICAL CORE CURRICULUM
A81 PEDIATRIC YEAR IN REVIEW
A83 GREAT CASES: CLINICAL, RADIOLOGIC, AND PATHOLOGIC CORRELATIONS BY MASTER CLINICIANS
A91 HOW TO ACHIEVE GLOBAL EQUITY IN MEDICATION ACCESS FOR CHRONIC RESPIRATORY DISEASES: CHALLENGES AND OPPORTUNITIES
A82 BREAKING NEWS: 2025 CLINICAL TRIAL RESULTS IN PULMONARY MEDICINE
A85 REGULATORS OF LUNG REMODELING AND REGENERATION ACROSS THE AGES
B8 PULMONARY VIRUS INFECTIONS ACROSS THE LIFESPAN
B13 ATS PRESIDENT’S SYMPOSIUM: ALPHA-1 BREAKTHROUGHS: NEW DISCOVERIES IN MECHANISMS, DIAGNOSIS & TREATMENT OF LUNG DISEASE IN ALPHA 1 ANTITRYPSIN DEFICIENCY
PCC2 PEDIATRIC CLINICAL CORE CURRICULUM
B85 OBSTRUCTIVE AIRWAY AND LUNG DISEASE BEGINS IN THE WOMB
B88 NOVEL MANAGEMENT STRATEGIES IN BRONCHIECTASIS
B82 MECHANICAL VENTILATION OF THE FUTURE: NEW FOUNDATIONS FOR VENTILATOR STRATEGIES
G5 RECOGNITION AWARDS FOR SCIENTIFIC ACCOMPLISHMENTS
G3 RESPIRATORY HEALTH AWARDS CEREMONY
C7 NEXT STEPS: ENHANCING RESEARCH TRIALS IN PULMONARY REHABILITATION TO IMPROVE REAL WORLD IMPLEMENTATION
C3 PEDIATRIC CLINICAL CHEST ROUNDS
C2 TYPE 2 INFLAMMATION IN COPD: A PRO AND CON DEBATE
C12 CHAIR’S SYMPOSIUM: CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS-TIME FOR THE TWAIN TO MEET IN CLINICAL TRIALS?
C90 EARLY STAGES OF TUBERCULOSIS INFECTION: UPDATES ON AN EVER-CHANGING PARADIGM
C85 ATS GUIDELINES: CONTROVERSIES IN THE MANAGEMENT OF CAP AND ARDS
D4 AI-DRIVEN INNOVATIONS IN PULMONARY AND CRITICAL CARE MEDICINE: A LOOK AHEAD
D9 SHARED MECHANISTIC INSIGHTS IN INTERSTITIAL LUNG DISEASE AND PULMONARY HYPERTENSION: THE ENDOTHELIAL CONNECTION
PCC3 PEDIATRIC CLINICAL CORE CURRICULUM
D83 POST-INFECTIOUS PULMONARY COMPLICATIONS: TB, SARS-COV-2, AND BEYOND
D85 RESPIRATORY MANIFESTATIONS OF ANCA-ASSOCIATED VASCULITIS: LESSONS FROM RECENTLY COMPLETED RCTS
All Access Pass
$560 member $700 non-member
Access to both Abstract and Scientific Symposia ATS 2025 Conference Highlight packages, including ePosters
Accessible until March 2026
CME is not available for on demand sessions.
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
